ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,692.19
      1.38%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. ETFs
      4. UK
      5. LSE

      6. Hsbc S&p 500 (HSPX) Quote

      Hsbc S&p 500

      Hsbc S&p 500 (HSPX)

      LSE
      4,394.40
      7.95
      (0.18%)
      Closed July 13 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      4,394.40
      Bid
      4,394.40
      Ask
      4,394.80
      Volume
      11,473
      4,350.05 Day's Range 4,395.00
      0.00 52 Week Range 0.00
      Market Cap
      844.95B
      Previous Close
      4,386.45
      Open
      4,390.00
      Last Trade
      41
      @
      4394.4
      (UT)
      Last Trade Time
      Financial Volume
      501,960p
      VWAP
      4,375.1453
      Average Volume (3m)
      -
      Shares Outstanding
      19,262,728,000
      Dividend Yield
      -
      PE Ratio
      25.33
      Earnings Per Share (EPS)
      1.22
      Revenue
      65.91B
      Net Profit
      23.53B

      About Hsbc S&p 500

      Sector
      Offices-bank Holding Company
      Industry
      Offices-bank Holding Company
      Website
      www.hsbc.com
      Headquarters
      London, Gbr
      Founded
      1970
      Hsbc S&p 500 is listed in the Offices-bank Holding Company sector of the London Stock Exchange with ticker HSPX. The last closing price for Hsbc S&p 500 was 4,386.45p. Over the last year, Hsbc S&p 500 shares have traded in a share price range of 0.00p to 0.00p.

      Hsbc S&p 500 currently has 19,262,728,000 shares outstanding. The market capitalization of Hsbc S&p 500 is £844.95 billion. Hsbc S&p 500 has a price to earnings ratio (PE ratio) of 25.33.

      HSPX Latest News

      More News

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 24 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 24 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 23 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 23 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 22 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 22 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 19 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 19 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 18 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 18 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 17 January 2024 Fund: Share HSBC Redeemed S&P 500 since Ex UCITS Valuation Shares Previous NET Asset NAV per Dividend ETF Date ISIN Code in Issue Currency...

      January 17 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 15 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 15 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 12 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 12 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 11 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 11 2024
      UK Regulatory

      HSBC ETFs S&P 500 UCITS ETF $ Net Asset Value(s)

      HSBC ETFs S&P 500 UCITS ETF $ 10 January 2024 Share Fund: HSBC Redeemed S&P 500 since UCITS Valuation Shares in Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code Issue...

      January 10 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000SP
      40000000SP
      120000000SP
      260000000SP
      520000000SP
      1560000000SP
      2600000000SP

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      VEVVicinity Motor Corporation
      $ 0.7131
      (122.15%)
      		116.26M
      QLGNQualigen Therapeutics Inc
      $ 0.428851
      (108.89%)
      		420.2M
      IVPInspire Veterinary Partners Inc
      $ 10.52
      (88.19%)
      		41.79M
      TOYOTOYO Company Ltd
      $ 2.699
      (74.13%)
      		56.65M
      NISNNiSun International Enterprise Development Group Company Ltd
      $ 9.11
      (51.33%)
      		7.4M
      SISIShineco Inc
      $ 0.8446
      (-60.16%)
      		6.71M
      MCACMonterey Capital Acquisition Corporation
      $ 3.54
      (-49.50%)
      		364.7k
      MCACUMonterey Capital Acquisition Corporation
      $ 7.64
      (-28.40%)
      		2.61k
      GENEGenetic Technologies Ltd
      $ 0.80
      (-27.93%)
      		780.46k
      KZIAKazia Therapeutics Ltd
      $ 0.8975
      (-27.62%)
      		25.62M
      QLGNQualigen Therapeutics Inc
      $ 0.428851
      (108.89%)
      		420.2M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.237
      (-1.54%)
      		286.13M
      NVDANVIDIA Corporation
      $ 129.24
      (1.44%)
      		251.65M
      AGRIAgriFORCE Growing Systems Ltd
      $ 0.1001
      (21.92%)
      		192.82M
      LCIDLucid Group Inc
      $ 4.25
      (25.00%)
      		167.79M

      Discussion

      View Full Feed
      oystersnbeer oystersnbeer 1 minute ago
      VOTE VOTE;

      That’s a keeper !!!
      doc2016 doc2016 1 minute ago
      anyway, gemini on further query responded:
      "can a defendant argue poor representation by attorney if they represented themselves?
      edit

      Show drafts
      expand_more
      volume_up


      1
      No, a defendant cannot argue poor representation by an a
      mascale mascale 3 minutes ago
      Anyone notes Waterchaser delusional, unable to seriously post.
      HIRU
      Golden Cross Golden Cross 4 minutes ago
      brother
      SMCE
      RC_702 RC_702 4 minutes ago
      Wow, I just realized that someone is just like my grandmother!

      I remember sending her a letter telling her about all the exciting, adventures that I had over the summer. Rock climbing! Belaying! Repelling! Amazing hikes!

      Her only response was that I miss spelled a cou
      SFRX
      Hoghead7 Hoghead7 4 minutes ago
      $.697 from $.60 in 2 days on average volume of over 76M shares. As previously stated numerous times, share price increases faster on heavier volume than when it declines. Never, in all history, has the SP declines 50% in a week, but has increased 50% in a week several times. It's possible it decl
      FCEL
      tschussmann1 tschussmann1 5 minutes ago
      Actually, I think having the stock symbol on the medication is brilliant...as long as the medication works. Anytime someone taking it (or their family) thinks: "Wow, I am feeling better than I have in a while", they know where to look for investment purposes. I would love to see AVXL on those caps
      AVXL
      doc2016 doc2016 5 minutes ago
      or, #4?

      :4. Ineffective Assistance of Counsel
      If a defendant can demonstrate that their counsel's performance was so deficient that it deprived them of a fair trial, the Supreme Court may review the case. This is protected under the Sixth Amendment and can include situations wh
      Nemesis18 Nemesis18 6 minutes ago
      You'll find yourself on the wrong side of history soon enough, so you shall inherited nothing, I'm afraid ☝️🤷🏻‍♂️
      NWBO
      VVVVVV VVVVVV 6 minutes ago
      Well, I would tend to agree with you however, there seems to be a discrepancy with the damage witnesses. Which could prolong the trial dates. These infringers know by now, they’re not going to prove these patents invalid. The recent Alice and ex parte reexamination decisions, basically sealed tha
      VPLM
      fredscott36 fredscott36 6 minutes ago
      sonterra: poop, if true......our appeal was that the 15 alleged perp banks should be included in the defendant class, with UBS......LIBOR ANITRUST CRIMES.....of the century..............???.......

      we "understand" that UBS and plaintiff have a "resolution" but that on our appeal, THE U
      UBS
      tredenwater2 tredenwater2 7 minutes ago
      “ controlling the shares very guardedly"

      Trickle selling only enough shares to cover your quarterly burn rate to me is guarding our shares. Not selling large chunk’s of shares in secondaries 20% or 30% below market value causing wild swings down and up often blindsiding shareholders
      AVXL
      Zardiw Zardiw 7 minutes ago
      $QLGN +111% #DDAmanda Video Analysis - #1 Stock Scanner/Screener

      https://www.youtube.com/watch?v=thDysgkOpu4

      Z
      QLGN
      keepsinvesting keepsinvesting 7 minutes ago
      Market in range now, lets see if 5500 ES gets tested in comjng weeks
      rosemountbomber rosemountbomber 7 minutes ago
      And, it is going to get worse. The recent Supreme Court decision that overturned the long-held precedent known as the Chevron deference. What that decision does is it substitutes the uninformed opinions of unelected judges for the expert opinion of the people hired by the Senate-approved administr
      AMRN
      RobotDroid RobotDroid 7 minutes ago
      Agree, there is much more behind the curtain, just waiting for it to drop. 'Final curtain call', and hopefully a standing ovation.
      NWBO
      Zardiw Zardiw 7 minutes ago
      $QLGN +111% #DDAmanda Video Analysis - #1 Stock Scanner/Screener

      https://www.youtube.com/watch?v=thDysgkOpu4

      Z
      QLGN
      mascale mascale 8 minutes ago
      Waterchaser even alleges English language: Serbian(?)!

      Re: #61,013: @mascale - Waterchaser shown way too stupid: All posts
      What? English pls.
      We don’t understand Serbian language in the US… we speak English here.
      HIRU
      jxyzobrien jxyzobrien 9 minutes ago
      lower vpoc targets

      https://investorshub.advfn.com/uimage/uploads/2024/7/13/psrkfes_vpoc_12_lower.PNG
      zab zab 9 minutes ago
      Siemens machine for the scan, they have come a long way in my lifetime. The nuclear dye is still warming in the IV, but better than 20 years ago. My father had heart attacks, World War II took its toll, along with the New York Central, his employer.
      Seminole Red Seminole Red 12 minutes ago
      Republicans lack the killer instinct
      Gmenfan Gmenfan 13 minutes ago
      House Republicans Fail To Hold Merrick Garland In Contempt Of Congress
      he Republican majority under House Speaker Mike Johnson of Louisiana failed to hold Attorney General Merrick Garland in contempt of Congress on Thursday.

      Rep. Anna Paulina Luna, R-Fla., introduced the resolu
      02opida 02opida 13 minutes ago
      WORKING INTO THE 80's
      02opida 02opida 13 minutes ago
      7.13.24

      Your Recent History

      LSE
      HSPX
      Hsbc S&p 500
      Delayed Upgrade Clock